Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study

This publication has 22 references indexed in Scilit:

• Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder
  Blood, 2004
• Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population
  Annals of Internal Medicine, 2004
• Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial
  Blood, 2004
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Prevalence of factor V G1691A (factor V‐Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population
  American Journal of Hematology, 2002
• Venous thromboembolism in young women. Role of thrombophilic mutations and oral contraceptive use
  European Heart Journal, 2002
• Management of venous thromboembolism in pregnancy
  Best Practice & Research Clinical Obstetrics & Gynaecology, 2001
• Genetic susceptibility to preeclampsia: Roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68–base pair insertion at nucleotide 844 of the gene for cystathionine β-synthase, and factor V Leiden mutation
  American Journal of Obstetrics and Gynecology, 2001
• Antiphospholipid antibodies in women at risk for preeclampsia
  American Journal of Obstetrics and Gynecology, 2001
• Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial
  American Journal of Obstetrics and Gynecology, 2000